Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31truefalse2024-01-01falseMedical device consultancy1115true 04264871 2024-01-01 2024-12-31 04264871 2023-01-01 2023-12-31 04264871 2024-12-31 04264871 2023-12-31 04264871 2023-01-01 04264871 1 2024-01-01 2024-12-31 04264871 d:Director1 2024-01-01 2024-12-31 04264871 e:ComputerEquipment 2024-12-31 04264871 e:ComputerEquipment 2023-12-31 04264871 e:ComputerEquipment e:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 04264871 e:CurrentFinancialInstruments 2024-12-31 04264871 e:CurrentFinancialInstruments 2023-12-31 04264871 e:CurrentFinancialInstruments e:WithinOneYear 2024-12-31 04264871 e:CurrentFinancialInstruments e:WithinOneYear 2023-12-31 04264871 e:ShareCapital 2024-12-31 04264871 e:ShareCapital 2023-12-31 04264871 e:ShareCapital 2023-01-01 04264871 e:SharePremium 2024-01-01 2024-12-31 04264871 e:SharePremium 2024-12-31 04264871 e:SharePremium 1 2024-01-01 2024-12-31 04264871 e:SharePremium 2023-12-31 04264871 e:SharePremium 2023-01-01 04264871 e:CapitalRedemptionReserve 2024-01-01 2024-12-31 04264871 e:CapitalRedemptionReserve 2024-12-31 04264871 e:CapitalRedemptionReserve 1 2024-01-01 2024-12-31 04264871 e:CapitalRedemptionReserve 2023-12-31 04264871 e:CapitalRedemptionReserve 2023-01-01 04264871 e:OtherMiscellaneousReserve 2024-01-01 2024-12-31 04264871 e:OtherMiscellaneousReserve 2024-12-31 04264871 e:OtherMiscellaneousReserve 1 2024-01-01 2024-12-31 04264871 e:OtherMiscellaneousReserve 2023-12-31 04264871 e:OtherMiscellaneousReserve 2023-01-01 04264871 e:RetainedEarningsAccumulatedLosses 2024-01-01 2024-12-31 04264871 e:RetainedEarningsAccumulatedLosses 2024-12-31 04264871 e:RetainedEarningsAccumulatedLosses 1 2024-01-01 2024-12-31 04264871 e:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 04264871 e:RetainedEarningsAccumulatedLosses 2023-12-31 04264871 e:RetainedEarningsAccumulatedLosses 2023-01-01 04264871 d:FRS102 2024-01-01 2024-12-31 04264871 d:Audited 2024-01-01 2024-12-31 04264871 d:FullAccounts 2024-01-01 2024-12-31 04264871 d:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 04264871 d:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 04264871 e:ShareCapital 1 2024-01-01 2024-12-31 04264871 f:PoundSterling 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure

Registered number: 04264871










EMERGO CONSULTING (UK) LIMITED










FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

 
EMERGO CONSULTING (UK) LIMITED
REGISTERED NUMBER: 04264871

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
273
982

Current assets
  

Debtors: amounts falling due within one year
 5 
652,959
449,940

Cash at bank and in hand
  
244,920
175,228

  
897,879
625,168

Creditors: amounts falling due within one year
 6 
(150,613)
(581,872)

Net current assets
  
 
 
747,266
 
 
43,296

  

Net assets
  
747,539
44,278


Capital and reserves
  

Called up share capital 
  
1,251
1,251

Share premium account
  
302,428
302,428

Capital redemption reserve
  
154
154

Capital contribution reserve
  
700,000
-

Profit and loss account
  
(256,294)
(259,555)

  
747,539
44,278


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 17 June 2025.




J A Genovesi
Director

The notes on pages 3 to 7 form part of these financial statements.

Page 1

 
EMERGO CONSULTING (UK) LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024


Called up share capital
Share premium account
Capital redemption reserve
Capital contribut'n reserve
Profit and loss account
Total equity

£
£
£
£
£
£


At 1 January 2023
1,251
302,428
154
-
(181,951)
121,882



Loss for the year
-
-
-
-
(77,604)
(77,604)



At 1 January 2024
1,251
302,428
154
-
(259,555)
44,278



Profit for the year
-
-
-
-
3,261
3,261

Capital introduced
-
-
-
700,000
-
700,000


At 31 December 2024
1,251
302,428
154
700,000
(256,294)
747,539


The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
EMERGO CONSULTING (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

Emergo Consulting (UK) Limited is a private company limited by shares, incorporated in England and Wales (registered number: 04264871). Its registered office is Compass House, Vision Park, Histon, Cambridge, CB24 9BZ. The principal activity throughout the year continued to be that of medical device consultancy.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

At the year end date the Company's profit and loss reserves were negative due to losses made to date. The Company will continue to receive support from the parent company and on this basis the accounts have been prepared on a going concern basis.

 
2.3

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is pounds sterling.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Page 3

 
EMERGO CONSULTING (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.4

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.5

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

 
2.6

Financial instruments

The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities such as bank and cash balances, trade and other accounts receivable and payable, loans from banks and other third parties and loans to and from related parties.
Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at the transaction price and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade receivables and payables, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost.
Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Page 4

 
EMERGO CONSULTING (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

3.


Employees

The average monthly number of employees, including directors, during the year was 11 (2023 - 15).


4.


Tangible fixed assets





Computer equipment

£



Cost


At 1 January 2024
3,676



At 31 December 2024

3,676



Depreciation


At 1 January 2024
2,694


Charge for the year on owned assets
709



At 31 December 2024

3,403



Net book value



At 31 December 2024
273



At 31 December 2023
982


5.


Debtors

2024
2023
£
£


Trade debtors
14,493
107,150

Amounts owed by group undertakings
634,863
336,042

Other debtors
-
3,011

Prepayments and accrued income
3,603
3,737

652,959
449,940


Page 5

 
EMERGO CONSULTING (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
242
4,746

Amounts owed to group undertakings
39,317
422,244

Other taxation and social security
4,431
4,050

Other creditors
106,623
150,832

150,613
581,872



7.


Reserves

Share premium account

The share premium account represents amounts paid in excess of the par value of share capital issued and is not distributable.

Capital redemption reserve

The capital redemption reserve represents the nominal value of share capital previously bought back by the company and is not distributable.

Capital contribution reserve

During the year, the parent company Emergo Consulting B.V made a capital contribution of £700,000. This amount is considered to be distributable.

Profit and loss account

The profit and loss account is made up of the cumulative trading profits and losses of the Company and where the balance is positive, it is considered to be distributable.


8.


Pension commitments

The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £24,260 (2023: £31,278). There were no contributions payable to the fund at either balance sheet date.


9.


Related party transactions

As a wholly owned subsidiary of Emergo Europe Consulting BV, the Company is exempt from the requirements of FRS 102 to disclose transactions with other members of the group.

Page 6

 
EMERGO CONSULTING (UK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

10.


Controlling party

The largest and smallest parent company of the group in which these financial statements are consolidated is UL Solutions Inc. The registered office is 251 Little Falls Drive, Delaware, 19808, United States.
The ultimate controlling party is A Genovesi.


11.


Auditors' information

The auditors' report on the financial statements for the year ended 31 December 2024 was unqualified.

The audit report was signed on 17 June 2025 by Kirstie Wilson ACA DChA (Senior Statutory Auditor) on behalf of Shorts.

 
Page 7